葡萄膜炎中的生物标志物与替代终点:定量影像的影响
本文为叙述性综述,检索当前世界文献及临床试验注册数据,结合专家知识,阐述定量影像(自动分析与测量算法)如何为葡萄膜炎疾病活动提供客观的仪器化测量指标。综述指出当前疾病活动评估多基于主观临床估计、敏感性较低且判别力与可靠性不佳,而黄斑中心凹厚度(CMT)测量黄斑水肿(ME)严重程度是定量影像最成熟的范例,其他炎症参数(前房细胞、玻璃体混浊、视网膜血管渗漏、脉络膜视网膜浸润)的定量影像方法正在开发和验证中。结论认为葡萄膜炎学界需评估这些工具并达成新的疾病活动测量共识,敏感且具判别力的疾病活动测量方法的开发、验证和采用是一个未满足的需求。
要点
- 当前葡萄膜炎疾病活动评估多基于主观临床估计,敏感性较低,判别力与可靠性不佳。
- 用OCT测量黄斑中心凹厚度(CMT)评估黄斑水肿(ME)严重程度是葡萄膜炎定量影像最成熟的范例。
- 前房细胞、玻璃体混浊、视网膜血管渗漏和脉络膜视网膜浸润的定量影像方法正在开发和验证中。
核心结论
- 随着新的葡萄膜炎定量影像方法被提出,葡萄膜炎学界需将这些工具与当前主观临床估计进行对比评估,并就如何测量葡萄膜炎疾病活动达成新的共识。
- 敏感且具判别力的疾病活动测量方法的开发、验证和采用是一个未满足的需求,有潜力改变葡萄膜炎患者的药物开发和常规临床诊疗。
研究设计与样本
- 本文为叙述性综述,基于对当前世界文献中与葡萄膜炎定量影像技术相关术语的检索,辅以临床试验注册数据和眼科学中替代终点与结局指标的专家知识。
主要发现
- 当前疾病活动测量主要基于主观临床估计,相对不敏感,判别力和可靠性不佳。
- 葡萄膜炎定量影像的发展最成熟地体现在使用光学相干断层扫描(OCT)测量黄斑中心凹厚度(CMT)以评估黄斑水肿(ME)的严重程度。
- CMT在黄斑水肿患者临床评估中的变革性作用为其他形式定量影像的发展和影响提供了范例。
- 定量影像方法目前正在针对其他关键炎症参数(如前房细胞、玻璃体混浊、视网膜血管渗漏和脉络膜视网膜浸润)进行开发和验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Uveitis is a major cause of sight loss across the world. The reliable assessment of intraocular inflammation in uveitis ('disease activity') is essential in order to score disease severity and response to treatment. In this review, we describe how 'quantitative imaging', the approach of using automated analysis and measurement algorithms across both standard and emerging imaging modalities, can develop objective instrument-based measures of disease activity. METHODS: This is a narrative review based on searches of the current world literature using terms related to quantitative imaging techniques in uveitis, supplemented by clinical trial registry data, and expert knowledge of surrogate endpoints and outcome measures in ophthalmology. RESULTS: Current measures of disease activity are largely based on subjective clinical estimation, and are relatively insensitive, with poor discrimination and reliability. The development of quantitative imaging in uveitis is most established in the use of optical coherence tomographic (OCT) measurement of central macular thickness (CMT) to measure severity of macular edema (ME). The transformative effect of CMT in clinical assessment of patients with ME provides a paradigm for the development and impact of other forms of quantitative imaging. Quantitative imaging approaches are now being developed and validated for other key inflammatory parameters such as anterior chamber cells, vitreous haze, retinovascular leakage, and chorioretinal infiltrates. CONCLUSIONS: As new forms of quantitative imaging in uveitis are proposed, the uveitis community will need to evaluate these tools against the current subjective clinical estimates and reach a new consensus for how disease activity in uveitis should be measured. The development, validation, and adoption of sensitive and discriminatory measures of disease activity is an unmet need that has the potential to transform both drug development and routine clinical care for the patient with uveitis.
引用
- Denniston AK, Keane PA, Srivastava SK, et al. Biomarkers and Surrogate Endpoints in Uveitis: The Impact of Quantitative Imaging. Invest Ophthalmol Vis Sci. 2017. PMID: 28655060. doi:10.1167/iovs.17-21788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。